Assess whether to escalate a case to peer review (206d62)

SITUATION A rural hospital with long transfer times cannot treat nurses silencing the same BPA 70% of the time as incidental context on unexpected mortality case series. Risk-model validation lead must close to escalate a case to peer review from that extract under Healthcare / Pediatric Protocols.

DECISION Risk-model validation lead in a rural hospital with long transfer times must choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold using unexpected mortality case series after nurses silencing the same BPA 70% of the time.

HYPOTHESES TO TEST 1. The population in unexpected mortality case series is the one nurses silencing the same BPA 70% of the time named, so Proceed under protocol follows for this Pediatric Protocols file. 2. The population in unexpected mortality case series is adjacent only to nurses silencing the same BPA 70% of the time; Pause the pathway is the honest Healthcare call. 3. A rural hospital with long transfer times already contained nurses silencing the same BPA 70% of the time before unexpected mortality case series arrived; no new Pediatric Protocols path. 4. Provenance on unexpected mortality case series after nurses silencing the same BPA 70% of the time is broken; do not pick Proceed under protocol or Pause the pathway yet.

ANALYSIS REQUIRED 1. Quantify who is harmed if unexpected mortality case series is wrong. 2. Separate a documented exception from an OCR-relevant gap in a rural hospital with long transfer times. 3. Validate clinical-outcome evidence and protocol steps in unexpected mortality case series after nurses silencing the same BPA 70% of the time. 4. For this Healthcare Pediatric Protocols file, read unexpected mortality case series against nurses silencing the same BPA 70% of the time and write the one fact that would move to escalate a case to peer review for risk-model validation lead.

RECOMMENDATION Choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold on this Healthcare / Pediatric Protocols packet (unexpected mortality case series after nurses silencing the same BPA 70% of the time). If unexpected mortality case series cannot force a Healthcare label under Pediatric Protocols, stop. If unexpected mortality case series after nurses silencing the same BPA 70% of the time cannot support Proceed under protocol versus Pause the pathway on this Healthcare Pediatric Protocols close, risk-model validation lead must state the unresolved clinical or safety evidence requirement explicitly.

COMMAND RETURNS - Bottom-line Healthcare option on to escalate a case to peer review, then the evidence in unexpected mortality case series, then the action for risk-model validation lead - Hypothesis scorecard against unexpected mortality case series: supported / rejected / untestable - Pediatric Protocols finding in unexpected mortality case series that a second reviewer can re-perform - Missing page in unexpected mortality case series after nurses silencing the same BPA 70% of the time, if any